Quantcast

Latest pharmaceutical Stories

2014-10-21 23:13:16

Lawrence Livermore National Laboratory researchers recently published an article in PLOS ONE detailing the use of supercomputers to link proteins to drug side effects. The research showed their computational model of predicting side effects to be more predictive than current statistical methods in two cases, and the calculations also predicted new potential side effects. Livermore, California (PRWEB) October 21, 2014 New medications created by pharmaceutical companies have helped millions...

2014-10-21 20:23:11

LONDON, Oct. 21, 2014 /PRNewswire/ -- This region is home to more than half of the human beings in the world. The region has a steady economic growth. The GDP growth for 2014-2015 is forecasted to be more than 5% which is helped by growth in economies, robust credit growth and good labour markets. This growth has been seen by the global pharmaceutical companies who are investing heavily in this market. In 2012 the Chinese pharmaceutical market grew by more than 15%.This growth in the...

2014-10-21 16:28:05

CHENGDU, China, Oct. 21, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE MKT: TPI, the "Company"), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API), today reported that, on October 15, 2014, it received a notice from the NYSE MKT Staff indicating that the Company is below certain of the continued listing...

2014-10-16 08:31:37

TORONTO, Oct. 16, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), a pharmaceutical company, today announced it has completed a US$25 million offering of Class A Common Shares. The financing was led by a private equity partner that is committed to Highland's long-term success. The funds raised will provide, among other things, the necessary resources for Highland, through its wholly owned subsidiary Ironshore Pharmaceuticals & Development, Inc. to (i) complete the...

2014-10-16 08:31:11

-- Go Dropless(TM) campaign continues its momentum as cataract surgeons embrace the benefits of "going dropless" for their patients -- SAN DIEGO, Oct. 16, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a specialty pharmaceutical company focused on the development and commercialization of high quality and innovative sterile and topical compounded drug formulations, today announces its attendance, and related "Go Dropless!(TM)" events, at the 2014 American Academy...

2014-10-15 20:22:42

Company to make OFEV available to IPF community within 10 days, along with comprehensive patient support resources RIDGEFIELD, Conn., Oct. 15, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved OFEV® (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF). Granted Breakthrough Therapy designation during its review by the FDA, OFEV, capsules for oral use, taken twice...

2014-10-14 08:32:16

Distinguished research and clinical scientists team to unlock genome sequencing data SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- Cypher Genomics, Inc., the genome informatics company, announced today the formation of a scientific advisory board (SAB) to guide the development and implementation of Cypher's products, which include Mantis(TM), the genome interpretation software as a service offering, and Coral(TM), a biomarker discovery service. Drs. Kelly Bethel, Michael Hultner, Myla...

2014-10-02 20:22:35

NORTHBROOK, Ill., Oct. 2, 2014 /PRNewswire/ -- Astellas, a pharmaceutical company based in Northbrook, Ill., launched a new benefits program today to provide support for its almost 3,000 US-based employees. The program goes beyond traditional healthcare support to include legal aid for parents and in-laws, identity theft for the entire family and college coaching in addition to many other benefits. http://photos.prnewswire.com/prnvar/20140416/84970 "We recognize in life there's a...

2014-10-01 16:27:41

SAN DIEGO, Oct. 1, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Malcolm Lloyd-Smith has joined the executive management team as Chief Regulatory Officer. "We are very pleased to welcome Malcolm Lloyd-Smith to the Neurocrine leadership team as our Chief Regulatory Officer," said Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences. "Malcolm brings a wealth of worldwide regulatory experience and pharmaceutical...

2014-10-01 08:31:09

SHANGHAI, Oct. 1, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (WuXi) (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, announced today that it has acquired XenoBiotic Laboratories, Inc. (XBL), a contract research organization with 27 years of successful operation that provides bioanalytical, drug metabolism, and pharmacokinetic services to the pharmaceutical,...


Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related